Legacy Advisors, LLC Bristol Myers Squibb CO Transaction History

Legacy Advisors, LLC

$821 Million
Q2 2024

A detailed history of Legacy Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Legacy Advisors, LLC holds 9,776 shares of BMY stock, worth $505,908. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,776

Previous 11,304 13.52%

Holding current value

$505,908

Previous $613,000 33.93%

% of portfolio

0.05%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $61,502 - $80,968	-1,528 Reduced 13.52%	9,776 $405,000
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $94,040 - $106,624	1,960 Added 20.98%	11,304 $613,000
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $80,913 - $96,551	1,669 Added 21.75%	9,344 $479,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $1,505 - $1,682	-26 Reduced 0.34%	7,675 $445,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $9,683 - $10,752	152 Added 2.01%	7,701 $492,000
Q1 2023 May 01, 2023	SELL	$65.71 - $74.53 $19,515 - $22,135	-297 Reduced 3.79%	7,549 $523,000
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $18,832 - $22,299	275 Added 3.63%	7,846 $564,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $171 - $101,198	-1,317 Reduced 14.82%	7,571 $538,000
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $115,683 - $127,408	1,593 Added 21.84%	8,888 $684,000
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $54,102 - $64,873	880 Added 13.72%	7,295 $533,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $22,524 - $26,258	-420 Reduced 6.14%	6,415 $400,000
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $21,419 - $25,090	362 Added 5.59%	6,835 $404,000
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $31,636 - $34,451	511 Added 8.57%	6,473 $433,000
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $35,798 - $40,566	-620 Reduced 9.42%	5,962 $370,000
Q3 2020 Oct 08, 2020	BUY	$57.43 - $63.64 $35,606 - $39,456	620 Added 10.4%	6,582 $397,000
Q2 2020 Jul 09, 2020	SELL	$54.82 - $64.09 $252,117 - $294,749	-4,599 Reduced 43.55%	5,962 $351,000
Q1 2020 Apr 15, 2020	SELL	$46.4 - $67.43 $15,776 - $22,926	-340 Reduced 3.12%	10,561 $589,000
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $16,731 - $21,824	340 Added 3.22%	10,901 $700,000
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $469,221 - $584,832	9,286 Added 728.31%	10,561 $584,000
Q1 2018 Apr 17, 2018	SELL	$59.92 - $68.98 $7,490 - $8,622	-125 Reduced 8.93%	1,275 $75,000
Q4 2017 Jan 26, 2018	SELL	$59.94 - $65.35 $6,833 - $7,449	-114 Reduced 7.53%	1,400 $85,000
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $17,342 - $20,014	314 Added 26.17%	1,514 $96,000
Q4 2016 Nov 03, 2017	BUY	N/A	1,200	1,200 $70,000

Others Institutions Holding BMY

# of Institutions

2,402

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Bristol Myers Squibb CO Transaction History